Gamma-Glutamyl Transferase

Gamma-glutamyl transferase (GGT), also called gamma-glutamyltransferase, is an enzyme found on the outer surface of many cells, with especially high levels in the liver, bile ducts, kidneys, and pancreas. Its key job is helping your body manage glutathione, the body’s most abundant intracellular antioxidant. Glutathione protects cells from oxidative stress (cell damage caused by excess free radicals) and supports detoxification pathways. GGT helps “recycle” glutathione by breaking down glutathione outside cells and recovering cysteine, an amino acid needed to make fresh glutathione inside cells. In this way, GGT is part of your antioxidant maintenance system — when oxidative stress rises, GGT activity often rises too as the body tries to keep up with glutathione demand.

When GGT is measured in your blood, it provides information about liver and biliary (bile-duct) health as well as oxidative stress status. Typical lab ranges vary, but are often around 9–48 U/L in men and 9–32 U/L in women, depending on the laboratory and method. GGT is considered highly sensitive for detecting liver/bile-duct problems, but it is not highly specific — meaning it can be elevated for many reasons, including alcohol exposure, metabolic dysfunction, medications, smoking, and some chronic health conditions. This is why GGT is most meaningful when interpreted alongside other liver markers (ALT, AST, ALP, bilirubin) and your broader metabolic picture (waist circumference, glucose, lipids).

GGT matters because it can act like an early “check engine light” for the liver and metabolic system — often shifting before more obvious disease develops. While GGT is widely used to help detect liver injury and bile-duct obstruction or inflammation, research has shown it also strongly tracks with oxidative stress and insulin resistance, linking it to future risk of metabolic syndrome, type 2 diabetes, cardiovascular disease, and mortality. In other words, GGT is not only about the liver — it’s a marker of how much physiological stress your body is dealing with, particularly from metabolic overload and oxidative damage.

Large cohort studies show that higher GGT levels — even within the reference range — are associated with a higher likelihood of developing metabolic syndrome, a cluster that includes abdominal obesity, high blood pressure, elevated blood sugar, and unfavourable cholesterol patterns. Multiple studies also show a dose-dependent relationship between GGT and future diabetes risk, suggesting that rising GGT can reflect worsening insulin resistance and oxidative burden over time. Cardiovascular links are also consistent: higher GGT is associated with increased risk of coronary heart disease, cardiovascular mortality, atrial fibrillation, and heart failure outcomes. Data from the Framingham Heart Study found that people in the highest GGT quartile had meaningfully higher cardiovascular event rates than those in the lowest quartile, even after adjusting for traditional risk factors. Some research has even detected active GGT in atherosclerotic plaques, suggesting it may participate in damaging oxidative reactions within blood vessel walls.

For liver health specifically, GGT is particularly helpful for pattern recognition. It often rises in fatty liver disease (including NAFLD/MASLD) and in alcohol-related liver disease. In severe alcohol-related disease, GGT can become extremely high (sometimes >2000 U/L), whereas in fatty liver related to metabolic dysfunction, elevations are more commonly modest (often <200 U/L). GGT also rises in viral hepatitis, drug-induced liver injury, biliary obstruction, and autoimmune cholestatic diseases such as primary biliary cholangitis. Because GGT increases with bile-duct stress and oxidative load, persistently high levels can indicate that the body is operating under chronic metabolic pressure — making GGT a useful preventive marker when combined with diet, lifestyle, and metabolic data.

Dietary factors

Alcohol is one of the strongest and most consistent drivers of GGT. Even moderate drinking can raise GGT, and chronic drinking can lead to substantial elevations. Large datasets show a clear dose-response relationship, with GGT rising progressively as alcohol intake increases, and alcohol effects can amplify when paired with abdominal obesity. Beyond alcohol, diet quality matters: higher intake of red and processed meats is associated with higher GGT in observational research, likely influenced by heme iron and oxidative stress pathways. In contrast, fruit intake and broader plant-food patterns tend to show inverse relationships with GGT, consistent with the protective role of antioxidants and micronutrients from whole foods.

Lifestyle factors

Abdominal obesity (waist circumference) is strongly associated with higher GGT, reflecting fatty liver accumulation and oxidative/metabolic stress. Physical inactivity is linked to higher GGT, while regular exercise is associated with healthier GGT profiles. Smoking independently raises GGT and contributes to oxidative stress. Age and sex influence typical values: in men, GGT often rises with age (especially after ~40), and alcohol-related GGT responses can be stronger with increasing age. In women, the interaction between alcohol and body weight may be particularly relevant. Coffee intake is often associated with lower GGT in dose-dependent fashion in observational data.

Related biomarkers and patterns

GGT commonly moves alongside:

• ALT and AST (liver enzymes): help indicate liver-cell stress.

• ALP and bilirubin: help assess bile-duct involvement and bile flow issues.

• CRP (inflammation) and cardiometabolic markers such as fasting glucose/HbA1c, triglycerides, total cholesterol, and HDL.

• Iron markers: higher serum iron and transferrin saturation can be associated with higher GGT.

Micronutrient impacts

Because GGT reflects glutathione turnover and oxidative stress, diets rich in antioxidant-containing whole foods (especially fruits and colourful vegetables) are associated with healthier GGT patterns. Some studies note positive associations between certain vitamin supplements and GGT in population data, suggesting that nutrient form/context can matter compared with whole-food sources.

Environmental and medication influences

GGT is sensitive to enzyme-inducing medications (e.g., phenytoin, barbiturates and some other drugs), and it may rise with a range of chronic conditions including thyroid disorders, diabetes, kidney disease, pancreatic disease, and chronic lung disease. Exposure to toxins or drug-induced liver injury can also elevate GGT, which is why persistent or unexplained elevations should be reviewed clinically.

If your results are high

High GGT usually means your liver/bile system and antioxidant defenses are under increased demand. The most effective changes target alcohol exposure, abdominal adiposity, diet quality, and oxidative stress drivers.

Diet:

• The highest-impact step is to eliminate or strictly limit alcohol, as even moderate intake can elevate GGT and reductions can lower levels over weeks to months.

• Shift to a whole-food, plant-forward pattern with high antioxidant density: aim for at least 5 servings of fruit daily and 7–9 servings of vegetables daily, emphasising colourful produce.

• Reduce red and processed meat to no more than 1–2 servings per week, and choose proteins that are more strongly linked to healthier liver markers: legumes 3–4 servings per week (beans, lentils, chickpeas), and fatty fish 2–3 servings per week (salmon, sardines, mackerel).

• Choose whole grains (oats, brown rice, quinoa) over refined grains.

• If overweight, target 5–10% body weight loss, which is consistently associated with improvement and normalisation trends in GGT in fatty liver populations, and better metabolic control predicts GGT normalisation.

Lifestyle:

• Aim for ≥150 minutes/week of moderate aerobic exercise (brisk walking, cycling, swimming) plus resistance training twice weekly, as combined exercise and diet changes are most effective for improving liver enzymes.

• If you smoke, cessation is important because smoking independently raises GGT and oxidative stress.

• If you drink coffee and tolerate it, maintaining 2–4 cups/day is associated with lower GGT in observational studies.

• Prioritise sleep quality and stress reduction (as chronic stress increases oxidative burden), using consistent sleep timing and simple daily stress practices.

Supplements:

• A clinical trial supports fermented garlic extract for improving GGT in adults with elevated GGT over 12 weeks (two sachets daily in the study), with good tolerability.

• Antioxidant-support nutrients commonly discussed in this context include selenium (200 mcg/day), zinc (15–30 mg/day), vitamin C (500–1000 mg/day), vitamin E (400 IU/day of natural mixed tocopherols), and N-acetylcysteine (NAC) 600–1200 mg/day to support glutathione production — however, because supplements can interact with medications and medical conditions (and vitamin E may require extra caution in people with diabetes or those using blood thinners), use healthcare-provider guidance before starting.

Additional tests:

• To clarify the cause and risk pattern

• follow-up commonly includes: ALT

• AST

• ALP

• bilirubin

• a comprehensive metabolic panel

• CBC

• lipid profile

• fasting glucose/HbA1c

• hepatitis screening (HBsAg

• HCV Ab)

• iron studies. These help distinguish alcohol effects

• fatty liver patterns

• bile-duct involvement

If your results are low

Low GGT is typically not a clinical concern and is usually interpreted as a favourable or neutral finding. No specific diet, lifestyle, or supplement changes are typically needed based on low GGT alone.

1. Mitrić, A., & Castellano, I. (2023). Targeting gamma-glutamyl transpeptidase: A pleiotropic enzyme involved in glutathione metabolism and redox homeostasis. Free Radical Biology & Medicine, 208, 672–683. https://doi.org/10.1016/j.freeradbiomed.2023.09.020

2. Brennan, P. N., Dillon, J. F., & Tapper, E. B. (2022). Gamma-glutamyl transferase (Γ-GT)—An old dog with new tricks? Liver International, 42(1), 9–15. https://doi.org/10.1111/liv.15099

3. Kunutsor, S. K. (2016). Gamma-glutamyltransferase—Friend or foe within? Liver International, 36(12), 1723–1734. https://doi.org/10.1111/liv.13221

4. Pratt, D. S., & Kaplan, M. M. (2000). Evaluation of abnormal liver-enzyme results in asymptomatic patients. The New England Journal of Medicine, 342(17), 1266–1271. https://doi.org/10.1056/NEJM200004273421707

5. Lee, D. S., Evans, J. C., Robins, S. J., et al. (2007). GGT and metabolic syndrome, CVD, and mortality risk: The Framingham Heart Study. Arteriosclerosis, Thrombosis, and Vascular Biology, 27(1), 127–133. https://doi.org/10.1161/01.ATV.0000251993.20372.40

6. Onat, A., Can, G., Örnek, E., et al. (2012). Serum GGT: Independent predictor of diabetes, hypertension, metabolic syndrome, and coronary disease. Obesity, 20(4), 842–848. https://doi.org/10.1038/oby.2011.136

7. André, P., Balkau, B., Vol, S., Charles, M. A., & Eschwège, E. (2007). GGT and development of metabolic syndrome (DESIR cohort). Diabetes Care, 30(9), 2355–2361. https://doi.org/10.2337/dc07-0440

8. Ndrepepa, G., Colleran, R., & Kastrati, A. (2018). GGT and risk of atherosclerosis/coronary heart disease. Clinica Chimica Acta, 476, 130–138. https://doi.org/10.1016/j.cca.2017.11.026

9. Neuman, M. G., Malnick, S., & Chertin, L. (2020). GGT—An underestimated marker for cardiovascular disease and metabolic syndrome. Journal of Pharmacy & Pharmaceutical Sciences, 23(1), 65–74. https://doi.org/10.18433/jpps30923

10. National Library of Medicine. (n.d.). Gamma-glutamyl transferase (GGT) test (MedlinePlus).

11. Xing, M., Gao, M., Li, J., et al. (2022). Peripheral blood GGT characteristics in different liver diseases. Medicine, 101(1), e28443. https://doi.org/10.1097/MD.0000000000028443

12. Lee, D. H., Steffen, L. M., & Jacobs, D. R. (2004). Serum GGT and dietary factors (CARDIA study). The American Journal of Clinical Nutrition, 79(4), 600–605. https://doi.org/10.1093/ajcn/79.4.600

13. Ho, F. K., Ferguson, L. D., Celis-Morales, C. A., et al. (2022). GGT and mortality/liver/cardiovascular outcomes: UK Biobank. EClinicalMedicine, 48, 101435. https://doi.org/10.1016/j.eclinm.2022.101435

14. Reus, V. I., Fochtmann, L. J., Bukstein, O., et al. (2018). APA practice guideline for the pharmacological treatment of patients with alcohol use disorder. American Psychiatric Association.

15. Danielsson, J., Kangastupa, P., Laatikainen, T., Aalto, M., & Niemelä, O. (2013). Joint impacts of ethanol, BMI, age and gender on GGT. International Journal of Molecular Sciences, 14(6), 11929–11941. https://doi.org/10.3390/ijms140611929

16. Danielsson, J., Kangastupa, P., Laatikainen, T., Aalto, M., & Niemelä, O. (2014). Lifestyle factors and liver enzymes. World Journal of Gastroenterology, 20(33), 11743–11752. https://doi.org/10.3748/wjg.v20.i33.11743

17. Niemelä, O., Bloigu, A., Bloigu, R., Aalto, M., & Laatikainen, T. (2023). Liver enzymes, lifestyle risk factors, and medical conditions. Journal of Clinical Medicine, 12(13), 4276. https://doi.org/10.3390/jcm12134276

18. Ma, Q., Liao, X., Shao, C., et al. (2021). GGT normalisation associated with better metabolic control in NAFLD. BMC Gastroenterology, 21(1), 215. https://doi.org/10.1186/s12876-021-01790-w

19. Kim, H. N., Kang, S. G., Roh, Y. K., Choi, M. K., & Song, S. W. (2017). Fermented garlic extract improves hepatic function in adults with elevated GGT: RCT. European Journal of Nutrition, 56(5), 1993–2002. https://doi.org/10.1007/s00394-016-1318-6

20. Kinikini, M. (2017). GGT measurement and lipid infusion in severe malabsorption (case report). JPEN, 41(1_suppl), 24S–27S. https://doi.org/10.1177/0148607117742632